Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-3 of 3

Sort by

Sort Order Select

Journal Articles

Real-world outcomes of epcoritamab in relapsed/refractory diffuse large B-cell lymphoma (R/R DLBCL) following CAR T-cell therapy: A multicenter retrospective study from the trinetx global network

Syed Naqvi, Ejaz Shah, Firas Jafri, Syed Muhammad Ali Najafi, Manpreet Saini, Syed Abutalib, Maurizio Zangari, Frits van Rhee, Ankur Varma

Blood (2025) 146 (Supplement 1): 7247.

https://doi.org/10.1182/blood-2025-7247

Published: 2025

Journal Articles

Real-world outcomes and toxicities of elranatamab (ELRA) in relapsed/refractory multiple myeloma: A retrospective analysis using the trinetx global health research network.

Syed Naqvi, Ejaz Shah, Firas Jafri, Manpreet Saini, Syed Abutalib, Maurizio Zangari, Carolina Schinke, Sharmilan Thanendrarajan, Samer Al Hadidi, Frits van Rhee

Blood (2025) 146 (Supplement 1): 7597.

https://doi.org/10.1182/blood-2025-7597

Published: 2025

Journal Articles

Real-world outcomes and toxicities of talquetamab (Tal) in Relapsed/Refractory multiple myeloma (RRMM): A retrospective analysis using the trinetx global health research network.

Syed Naqvi, Manpreet Saini, Ejaz Shah, Firas Jafri, Syed Abutalib, Samer Al Hadidi, Carolina Schinke, Maurizio Zangari, Sharmilan Thanendrarajan, Frits van Rhee

Blood (2025) 146 (Supplement 1): 7595.

https://doi.org/10.1182/blood-2025-7595

Published: 2025